<DOC>
	<DOCNO>NCT02764658</DOCNO>
	<brief_summary>The investigator previous research demonstrate proteoglycan 4 ( PRG4 ) may biomarker identification severity COPD . PRG4 sensitive specific CRP confirm COPD severity acute exacerbation frequency . It relate 1-year force vital capacity decline COPD patient . The past study find Prg4 immunomodulatory factor regulate parathyroid hormone action hematopoietic cell mouse . Previous report show voluntary wheel run fluid flow shear stress promote expression Prg4 association pulmonary inflammation . COPD patient characterize progressive decrease lung function associate increase airway systemic inflammation . Pulmonary recovery ( PR ) able decrease acute exacerbation , maintain pulmonary function , increase exercise tolerance improve quality life COPD patient , unknown mechanism PRG4 . The current study aim study pulmonary inflammation effectiveness pulmonary recovery COPD Patients：The mechanism PRG 4 .</brief_summary>
	<brief_title>Proteoglycan 4 Mechanism Effectiveness Pulmaonry Recovery COPD Patients</brief_title>
	<detailed_description>The investigator previous research demonstrate proteoglycan 4 ( PRG4 ) may biomarker identification severity COPD . PRG4 sensitive specific CRP confirm COPD severity acute exacerbation frequency . It relate 1-year force vital capacity decline COPD patient . The past study find Prg4 immunomodulatory factor regulate parathyroid hormone action hematopoietic cell mouse . Previous report show voluntary wheel run fluid flow shear stress promote expression Prg4 association pulmonary inflammation . COPD patient characterize progressive decrease lung function associate increase airway systemic inflammation . Pulmonary recovery ( PR ) able decrease acute exacerbation , maintain pulmonary function , increase exercise tolerance improve quality life COPD patient , unknown mechanism PRG4 . The current study aim study pulmonary inflammation effectiveness pulmonary recovery COPD Patients：The mechanism PRG 4 . 1 . Proteoglycan 4 correlate pulmonary inflammation decline pulmonary function different phenotype COPD . 1-1 Classification characteristic、the severity disease、pulmonary functional test、exercise capacity blood sample collection routine analysis . 1-2 Human blood bio-bank molecular analysis : PRG4、IL-6、IL-8、TNFα、CRP &amp; IL-10 . 1-3 To investigate whether daily physical activity、hypoxia hyperinflation associate airway inflammation PRG4 COPD patient . 2 . The mechanism PRG 4 effectiveness PR AECOPD . 2-1 The PR program : The combination effect negative pressure ventilation exercise training program acute exacerbation COPD ( AECOPD ) . 2-2 To examine efficacy PR cytokine PRG4 protein . 2-3 Correlation PR effect PRG4：PR correlation PRG4、clinical progression、exercise tolerance、PFT change SpO2 exercise . 3 . In vitro cell culture research model 3-1 Pulmonary inflammatory model establishment：Human primary epithelium cell culture Beas-2B IL-1β、TNFα、LPS、IL-10 H2O2 effect . 3-2 Purification peripheral blood monocyte cells：Primary culture evaluate pulmonary inflammation treatment effect . 3-3 Hypoxia experiments：To test whether hypoxia induces regulation PRG4 protein different cytokine epithelial cell . 3-4 Inhibit PRG4：To prove mechanism PRG4 hypoxia model PRG4 siRNA。 4 . In vivo animal research model 4-1 Smoke-COPD mouse model establishment： 4-2 To determinate effect exercise train COPD mine . 4-3 To investigate PRG4 protein pulmonary inflammation effectiveness exercise training tissue serum mouse .</detailed_description>
	<criteria>Hospitalized patient acute exacerbation COPD 1 . GOLD diagnostic criterion base COPD , use inhale bronchodilator : first second forced expiratory volume ( FEV1.0 ) / force vital capacity ( FVC ) &lt; 70 % . 2 . Age ≧ 40 ≦ 80 year old , currently accept research project . 3 . Physician assess patient currently stable condition vital sign , complain dyspnea exercise , consult RT pulmonary rehabilitation . 4 . The purpose study researcher explain , researcher agree participate . Stable COPD outpatient 1 . GOLD diagnostic criterion base COPD , use inhale bronchodilator : first second forced expiratory volume ( FEV1.0 ) / force vital capacity ( FVC ) &lt; 70 % . 2 . Age ≧ 40 ≦ 80 year old , currently accept research project . 3 . The purpose study researcher explain , researcher agree participate . Hospitalized patient acute exacerbation COPD 1 . Unstable vital sign : blood pressure &lt; 90 mm Hg , blood oxygen level ( SpO2 ) Tx still &lt; 85 % . 2 . Associated neuromuscular function disorder hemiplegia independent walk function . 3 . Have diagnose severe mental disorder , dementia unable cooperate people . Stable COPD outpatient 1 . Over past three month acute infection state acute attack . 2 . Associated neuromuscular function disorder hemiplegia independent walk function . 3 . Have diagnose severe mental disorder , dementia unable cooperating people</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>